Brown Advisory Securities’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Brown Advisory Securities’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-310	Closed	-$16K	–	377
2018 Q4	$16K	Sell	310 -155	-33%	-$9.9K	﹤0.01%	382
2018 Q3	$31K	Hold	465	–	–	0.01%	408
2018 Q2	$54K	Buy	+465	New	+$46.7K	0.01%	383

Other funds holding SRRA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Brown Advisory Securities's SRRA Position: Q1 2019 in Review

Brown Advisory Securities sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2019, closing a stake of 310 shares — an estimated $16K sold.

Brown Advisory Securities first reported a position in SRRA in Q2 2018 and held it in 3 quarters. The position peaked at $54K in Q2 2018. 59 funds tracked by Wall St. Rank hold SRRA as of Q1 2019.

Brown Advisory Securities reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Brown Advisory Securities sold 310 Sierra Oncology, Inc. Common Stock shares in Q1 2019, an estimated $16K.
Brown Advisory Securities first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2018 and held it in 3 quarters.
Brown Advisory Securities's Sierra Oncology, Inc. Common Stock position peaked at $54K in Q2 2018.
59 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2019.

Based on Brown Advisory Securities's 13F filing for Q1 2019, filed 14 May 2019.